BMRN Should I Buy

Buy BMRN now for a long-term position. The stock is trading near a key pivot (~56.2) with neutral-to-stabilizing technicals, while options positioning is strongly call-skewed (bullish sentiment). The dominant catalyst is the pending Amicus acquisition (supported by multiple recent analyst upgrades/raised targets), which could re-rate the stock over the next 6–24 months. Near-term, the debt financing overhang and upcoming earnings can cause volatility, but for a beginner long-term investor with $50k–$100k and no desire to wait for a perfect entry, the current level is an acceptable entry point.

Price/levels: Current price 56.77 is just above the pivot (56.215). Nearby resistance sits at R1 57.843 then R2 58.848; support is at S1 54.588 then S2 53.583. Trend/momentum: MACD histogram is negative (-0.201) but contracting, which often signals downside momentum is fading rather than accelerating. RSI(6) ~48.8 is neutral, consistent with consolidation. Moving averages are converging, also suggesting a range-bound/stabilizing phase rather than a strong trend. Tactical read: Risk is defined by support ~54.6; a clean push above ~57.8 improves the short-term setup, but even without that breakout the current price is close enough to support to justify initiating a long-term position. Intellectia Proprietary Trading Signals - [AI Stock Picker](module://ai_stock_pick): No signal on given stock today. - [SwingMax](module://swingmax): No signal on given stock today.